Both in Pharmaceuticals
Arbutus Biopharma vs Annexon
Over the past year ABUS returned −10.0% and ANNX returned +45.8%; their daily moves had a correlation of 0.29.
ABUS −10.0% ANNX +45.8%Growth of $1, one year, split-adjusted
| Metric | ABUS | ANNX |
|---|---|---|
| Price | $4.05 | $4.49 |
| Market cap | $802.3M | $851.2M |
| Today | +4.38% | +7.16% |
| 1 month | −9.6% | +11.4% |
| 6 months | −8.4% | −21.2% |
| Year to date | −15.8% | −10.6% |
| 1 year | −11.6% | +41.6% |
| Revenue growth (YoY) | −90.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −512.0% | — |
| P/E (TTM) | 5.2× | — |
| Price / sales | 4.4× | — |
| Net cash | $89.5M | $209.2M |
| Dividend yield | — | — |
| Volatility (60d) | 38.1% | 65.5% |
| Short % of float | 15.6% | 20.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).